Quantum Biopharma (QNTM) Accounts Payables (2018 - 2025)

Quantum Biopharma's Accounts Payables history runs 8 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Accounts Payables fell 39.11% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 39.11% YoY), while the FY2025 annual figure was $2.0 million, down 39.11% from the prior year.
• Accounts Payables came in at $2.0 million for Q4 2025 at Quantum Biopharma, down from $3.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $7.5 million in Q4 2021 to a low of $2.0 million in Q4 2025.
• A 5-year average of $4.8 million and a median of $4.2 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables jumped 102.99% in 2021 and plunged 40.99% in 2023, its largest moves.
• Quantum Biopharma's Accounts Payables stood at $7.5 million in 2021, then dropped by 5.36% to $7.1 million in 2022, then slumped by 40.99% to $4.2 million in 2023, then retreated by 22.41% to $3.3 million in 2024, then plunged by 39.11% to $2.0 million in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $2.0 million, $3.3 million, and $4.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison